Literature DB >> 2179647

Helicobacter pylori: controversies and an approach to management.

J E Ormand1, N J Talley.   

Abstract

Helicobacter pylori (formerly, Campylobacter pylori) is a gram-negative, spiral-shaped bacterium with a strong affinity for gastric-type epithelium. Convincing evidence indicates that H. pylori plays an etiologic role in the development of chronic, nonspecific gastritis, and it may play an important role in the pathogenesis of duodenal ulcer disease. An etiologic role for this organism in chronic gastric ulceration, nonulcer dyspepsia, and gastric carcinoma is not established. Whereas the diagnosis of H. pylori infection is relatively straightforward, the questions of when and how to treat the infection do not have established answers. A high rate of recrudescence follows most currently used therapeutic interventions. Until the pathogenicity of H. pylori in clinical disease is further supported and additional treatment trials have been completed, a conservative management approach is recommended.

Entities:  

Mesh:

Year:  1990        PMID: 2179647     DOI: 10.1016/s0025-6196(12)62541-5

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  14 in total

1.  Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese.

Authors:  Y Kinoshita; C Kawanami; K Kishi; H Nakata; Y Seino; T Chiba
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

2.  Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation.

Authors:  P R Tarnasky; T O Kovacs; B Sytnik; J H Walsh
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

Review 3.  Helicobacter pylori and gastric cancer in the Middle East: a new enigma?

Authors:  Nawfal R Hussein
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

4.  Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays.

Authors:  N J Talley; D G Newell; J E Ormand; H A Carpenter; W R Wilson; A R Zinsmeister; G I Perez-Perez; M J Blaser
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

Review 5.  Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.

Authors:  A P Weston; D R Campbell; D H McGregor; R Cherian
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

Review 6.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

7.  Helicobacter pylori is associated with alterations in intestinal gas profile among patients with nonulcer dyspepsia.

Authors:  A Minocha; S Siddiqi; P S Rahal; R L Vogel
Journal:  Dig Dis Sci       Date:  1994-08       Impact factor: 3.199

8.  Social and geographical risk factors in Helicobacter pylori infection.

Authors:  C J Whitaker; A J Dubiel; O P Galpin
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

9.  Comparison of commercial serological tests for detection of Helicobacter pylori antibodies.

Authors:  N J Talley; L Kost; A Haddad; A R Zinsmeister
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

10.  Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state.

Authors:  L E Gustavson; J F Kaiser; A L Edmonds; C S Locke; M L DeBartolo; D W Schneck
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.